Showing Results for
- Academic Journals (11)
Search Results
- 11
Academic Journals
- 11
- Search Terms:
- 1From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): S M Trifilio [1]; C L Bennett [2, 3]; P R Yarnold [4]; J M McKoy [5]; J Parada [6, 7]; J Mehta [3]; G Chamilos [8]; F Palella [9]; L Kennedy [10]; K Mullane [11]; M S Tallman [3]; A Evens [3]; M H Scheetz [1];...
- 2From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): J S G Yeoh [1]; A Ausema [1]; P Wierenga [1]; G de Haan [1]; R van Os [1] The initial source of hematopoietic cells used for transplantation was bone marrow (BM).[1] However, owing to the faster regeneration...
- 3From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): M Schmidt-Hieber [1]; I W Blau [1]; R Trenschel [2]; R Andreesen [3]; G Stuhler [4]; H Einsele [4]; L Kanz [5]; U Keilholz [1]; O Marinets [1]; D W Beelen [2]; A A Fauser [6]; L Volin [7]; T Ruutu [7]; L...
- 4From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): R M Sobecks [1]; E J Ball [2]; J P Maciejewski [1, 3]; L A Rybicki [4]; S Brown [1]; M Kalaycio [1]; B Pohlman [1]; S Andresen [1]; K S Theil [5]; R Dean [1]; B J Bolwell [1] Allogeneic hematopoietic stem...
- 5From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): O Ringdén [1, 2]; M Remberger [1, 2]; P Svenberg [2]; B-M Svahn [2]; G Dahllöf [3]; B Gustafsson [4]; Z Hassan [2]; B Omazic [2]; M Uzunel [1]; J Aschan [2, 5]; L Barkholt [1, 2]; J Winiarski [4]; P Ljungman...
- 6From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): Y Loh [1]; Y Oyama [1]; L Statkute [1]; L Verda [1]; K Quigley [1]; K Yaung [1]; W Barr [2]; B Jovanovic [3]; R K Burt [1] No treatment for systemic sclerosis (SSc) has been shown to be curative to date. In...
- 7From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): M Eapen [1]; C A DeLaat [2]; K S Baker [3]; M S Cairo [4]; M J Cowan [5]; J Kurtzberg [6]; C G Steward [7]; P A Veys [8]; A H Filipovich [2] Chediak-Higashi syndrome (CHS) is a rare autosomal-recessive...
- 8From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): R H Matthews [1]; M Emami [1]; D G Connaghan [1]; H K Holland [1]; L E Morris [1] Busulfan (BU)-based chemotherapy is commonly used as conditioning treatment for hematopoietic stem cell transplantation...
- 9From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): J de la Fuente [1] Neonatal hematology constitutes a very accomplished second edition to a classical text in a field that has grown exponentially to cover all different components of haematology from what...
- 10From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): W Y Au [1]; W C Leung [2] Most recipients of allogeneic hematopoietic stem cell transplantation (HSCT) suffer from secondary infertility owing to gonadal damage from myeloablative conditioning. However, the...
- 11From: Bone Marrow Transplantation. (Vol. 39, Issue 7) Peer-ReviewedAuthor(s): F Agha-Hosseini [1, 2]; I Mirzaii-Dizgah [2, 3]; L Ghavamzadeh [2]; A Ghavamzadeh [2]; Z Tohidast-Acrad [1, 2] Bone marrow transplantation is being used as a therapy for hematological disease and other...